Stryker today announced it completed the acquisition of Cerus Endovascular. The financial details of the deal were not disclosed. Cerus Endovascular designs and develops neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular’s CE marked products, the Contour Neurovascular system and Neqstent could assisted flow diverter, will expand Stryker’s portfolio of aneurysm treatment solutions. […]
Cerus Endovascular
FDA clears Cerus Endovascular 027 microcatheters
Cerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters. Fremont, California-based Cerus Endocascular’s new microcatheters are available in two lengths. The company expects to submit for CE mark approval under the EU new Medical Devices Regulation later this year. Get the full story on our sister site, Medical Tubing + Extrusion.
FDA grants IDE approval for Cerus Endovascular’s Contour Neurovascular System clinical study
Cerus Endovascular announced today that it received FDA investigational device exemption for a trial for its Contour Neurovascular System. Fremont, Calif.–based Cerus’ Contour Neurovascular System is designed to treat intracranial aneurysms. Its creators made it of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome. It’s possible to self-anchor […]